- Chemours (NYSE:CC): Q2 Non-GAAP EPS of $1.23 beats by $0.29; GAAP EPS of $0.39 misses by $0.57.
- Revenue of $1.66B (+52.3% Y/Y) beats by $130M.
- Given strong second quarter results and continued business momentum, we now expect 2021 Adjusted EBITDA (prior Adjusted EBITDA* between $1.10 and $1.25 billion vs. $879M in FY20) and Adjusted EPS to be in the top end of our guidance ranges (prior guidance ~$2.84 and $3.56) vs. $3.33 consensus."
- Press Release
Chemours EPS beats by $0.29, beats on revenue
Recommended For You
More Trending News
About CC Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| CC | - | - |
| The Chemours Company | ||